Science Explorer Back to mapMap
Discussion
Company · Waltham · United States

Xilio Therapeutics (United States)

Research works
33
▲ 242% vs 2018-21
Citations
482
14.7 per fractional work
Top-10% rate
7.0%
all institutions 10.0%
Open access
49%
world 40%
International
15%
world 18%

Not ranked overall: Xilio Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Xilio Therapeutics (United States) work in?

In 2022-now, 51% of research at Xilio Therapeutics (United States) is in Health Sciences, 42% in Life Sciences. Its largest fields are Medicine (50%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (13%). It does 2.1× the world's share of Life Sciences.

Health Sciences: 13 fractional works · 50.9% of its workMedicine: 13 fractional works · 50.0% of its workOncology: 5 fractional works · 19.1% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 12.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 5.6% of its workPathology and Forensic Medicine: 1 fractional works · 2.1% of its workNeurology: 0 fractional works · 2.0% of its workEmergency Medicine: 0 fractional works · 1.7% of its workPhysiology: 0 fractional works · 1.5% of its workImmunology and Allergy: 0 fractional works · 1.3% of its workEpidemiology: 0 fractional works · 0.9% of its workRheumatology: 0 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workPsychiatry and Mental health: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.7% of its workGeneral Health Professions: 0 fractional works · 0.7% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workLife Sciences: 10 fractional works · 41.7% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 24.7% of its workMolecular Biology: 2 fractional works · 8.4% of its workCancer Research: 1 fractional works · 4.9% of its workGenetics: 1 fractional works · 4.4% of its workBiotechnology: 1 fractional works · 3.7% of its workCell Biology: 1 fractional works · 2.9% of its workClinical Biochemistry: 0 fractional works · 0.3% of its workImmunology and Microbiology: 3 fractional works · 12.6% of its workImmunology: 3 fractional works · 12.6% of its workNeuroscience: 1 fractional works · 3.7% of its workEndocrine and Autonomic Systems: 0 fractional works · 2.0% of its workNeurology: 0 fractional works · 1.3% of its workBehavioral Neuroscience: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.4% of its workToxicology: 0 fractional works · 0.2% of its workPhysical Sciences: 2 fractional works · 6.7% of its workEngineering: 1 fractional works · 2.7% of its workBiomedical Engineering: 1 fractional works · 2.7% of its workChemistry: 0 fractional works · 1.5% of its workOrganic Chemistry: 0 fractional works · 1.5% of its workComputer Science: 0 fractional works · 1.3% of its workArtificial Intelligence: 0 fractional works · 1.3% of its workMathematics: 0 fractional works · 0.7% of its workComputational Mathematics: 0 fractional works · 0.7% of its workMaterials Science: 0 fractional works · 0.4% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 0.7% of its workHealth: 0 fractional works · 0.7% of its workALL ITS WORKXilioTherapeutics…25fractional works, 2022-now
Life Sciences42%Physical Sciences7%Health Sciences51%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine1350.0%
    2. Health Professions00.7%
    3. Veterinary00.2%
    1. Biochemistry, Genetics and Molecular Biology624.7%
    2. Immunology and Microbiology312.6%
    3. Neuroscience13.7%
    4. Pharmacology, Toxicology and Pharmaceutics00.7%
    1. Engineering12.7%
    2. Chemistry01.5%
    3. Computer Science01.3%
    4. Mathematics00.7%
    5. Materials Science00.4%
    1. Social Sciences00.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.63× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 12.56× its world share, 3 worksImmunology and Micro…Neuroscience: 2.31× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.88× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.95× its world share, 0 worksChemistryComputer Science: 0.17× its world share, 0 worksComputer ScienceEngineering: 0.18× its world share, 1 worksEngineeringMaterials Science: 0.12× its world share, 0 worksMaterials ScienceMathematics: 0.56× its world share, 0 worksMathematicsHealth Professions: 0.25× its world share, 0 worksHealth ProfessionsMedicine: 2.60× its world share, 13 worksMedicineVeterinary: 1.63× its world share, 0 worksVeterinarySocial Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.6×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Immunology and Microbiology12.56×3 works
  2. Biochemistry, Genetics and Molecular Biology4.63×6 works
  3. Medicine2.60×13 works
  4. Neuroscience2.31×1 works
  5. Pharmacology, Toxicology and Pharmaceutics1.88×0 works
  6. Veterinary1.63×0 works
  7. Chemistry0.95×0 works
  8. Mathematics0.56×0 works
  9. Health Professions0.25×0 works
  10. Engineering0.18×1 works
  11. Computer Science0.17×0 works
  12. Materials Science0.12×0 works
  13. Social Sciences0.05×0 works

Who are the top researchers at Xilio Therapeutics (United States)?

Ranked on the quality score, Carl Uli Bialucha, Manoussa Fanny and Natalia V. Malkova lead among researchers whose main affiliation is Xilio Therapeutics (United States).

  1. 1 Carl Uli Bialucha United States · #619,502 worldwide 1.3k citations · 127 works
  2. 2 Manoussa Fanny United States · #721,788 worldwide 725 citations · 66 works
  3. 3 Natalia V. Malkova United States · #1,274,641 worldwide 1.6k citations · 97 works
  4. 4 Wilson Tan De Guzman United States · #1,771,070 worldwide 416 citations · 96 works
  5. 5 Ekta P. Patel United States · #2,174,510 worldwide 106 citations · 75 works
  6. 6 Meghan D. Duncan United States · #2,674,451 worldwide 202 citations · 20 works
  7. 7 Parker M. Johnson United States · #2,689,301 worldwide 388 citations · 91 works
  8. 8 Kurt A. Jenkins United States · #2,864,330 worldwide 275 citations · 73 works
All ranked researchers at Xilio Therapeutics (United States)

What are the most cited papers from Xilio Therapeutics (United States)?

The most cited paper from Xilio Therapeutics (United States) is "A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants" (Laurie B. Schenkel et al., 2021), with 80 citations. Next come "From Genotype to Phenotype—A Review of Kabuki Syndrome" (69) and "Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models" (32).

Most cited papers
#PaperReleasedCitations
1 A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants Laurie B. Schenkel et al. · Cell chemical biology Open access 11 Mar 2021 80
2 From Genotype to Phenotype—A Review of Kabuki Syndrome Kelly K. Barry, Michaelangelo Tsaparlis, Deborah Hoffman et al. · Genes Open access 29 Sep 2022 69
3 Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models Delphine Valente, Christine Mauriac, Thorsten Schmidt et al. · mAbs Open access 2020 32
4 XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer Kurt A. Jenkins, Miso Park, Magali Pederzoli-Ribeil et al. · Journal for ImmunoTherapy of Cancer Open access Dec 2023 21
5 IOLite: phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin–paclitaxel, with or without bevacizumab in patients with advanced cancer Timothy Anthony Yap, Alberto Bessudo, Erika Paige Hamilton et al. · Journal for ImmunoTherapy of Cancer Open access Mar 2022 19
All 30 most cited papers, with filters and sorting

Which keywords describe research at Xilio Therapeutics (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, Monoclonal Antibodies, Cancer Immunotherapy, Fc Receptors, Therapeutic Antibodies, Tumor Regression, Tumor Microenvironment and Innate Immunity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Immunotherapy4▲ 21×4 topics
  2. Monoclonal Antibodies3▲ 145×2 topics
  3. Cancer Immunotherapy3▲ 81×2 topics
  4. Fc Receptors3▲ 223×1 topic
  5. Therapeutic Antibodies3▲ 175×1 topic
  6. Tumor Regression3▲ 91×2 topics
  7. Inflammation2▲ 4.0×10 topics
  8. Tumor Microenvironment2▲ 17×3 topics
  9. Innate Immunity2▲ 20×2 topics
  10. CAR T Cells2▲ 90×1 topic
  11. Cancer Therapy2▲ 11×7 topics
  12. Chimeric Antigen Receptor2▲ 90×1 topic
  13. Tumor Targeting2▲ 34×2 topics
  14. Angiogenesis2▲ 18×5 topics
  15. Antigen Presentation2▲ 65×1 topic
  16. Cancer2▲ 4.3×9 topics
  17. Dendritic Cells2▲ 65×1 topic
  18. Immunity2▲ 15×2 topics
  19. Cancer Progression1▲ 26×4 topics
  20. Gene Therapy1▲ 26×2 topics
  21. Immune Checkpoint Blockade1▲ 41×1 topic
  22. PD-1 and PD-L11▲ 41×1 topic
  23. Targeted Therapy1▲ 19×4 topics
  24. Breast Cancer1▲ 16×4 topics

Which research topics does Xilio Therapeutics (United States) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Immunotherapy and Immune Responses and Cancer Immunotherapy and Biomarkers.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 Immunotherapy and Immune Responses Immunology 2 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Cancer Research and Treatments Biotechnology 1 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 1 works
  7. 7 Microtubule and mitosis dynamics Cell Biology 1 works
  8. 8 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
  9. 9 Cytokine Signaling Pathways and Interactions Oncology 1 works
  10. 10 Cancer-related Molecular Pathways Oncology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.3%not open50.7%

World: 40% of research is openly available.

with international co-authors15.0%domestic only85.0%

World: 18% is written across borders.

How has Xilio Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 242% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Waltham

All research institutions in Waltham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Xilio Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.